Home
Conditions
Neurofibromatosis 1

Clinical trial condition

Neurofibromatosis 1

Explore clinical trials studying Neurofibromatosis 1. Study availability and eligibility vary by location and protocol.

57 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Neurofibromatosis 1 trial results

Completed

Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

NCT06120036

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: Wellman Center for Photomedicine Boston, Massachusetts, United States

View Trial Details

Completed

Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN)

NCT04774289

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

NCT03531814

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial

NCT04879160

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T

NCT02332902

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +15 more
Locations: The University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details

Completed

Intervention Effectiveness on the Neurocognitive Functioning of Children and Adolescents With Neurofibromatosis Type 1

NCT05377008

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +15 more
Locations: Children's Hospital of Richmond at Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Medical Treatment of "High-Risk" Neurofibromas

NCT00846430

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +15 more
Locations: Helen DeVos Children's Hospital Grand Rapids, Michigan, United States

View Trial Details

Completed

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

NCT04435665

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibroma, Genetic Diseases, Inborn, +14 more
Locations: Center for Dermatology Clinical Research, Inc. Fremont, California, United States

Minnesota Clinical Study Center New Brighton, Minnesota, United States

Skin Search of Rochester, Inc. Rochester, New York, United States

DermResearch Austin, Texas, United States

View Trial Details

Completed

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1

NCT04991428

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: University of Manchester Manchester, Greater Manchester, United Kingdom

View Trial Details

Completed

From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1

NCT03826940

Conditions: Autism Spectrum Disorder, Behavior, Child Development Disorders, Pervasive, +19 more
Locations: ICNAS Coimbra, Portugal

View Trial Details

Neurofibromatosis 1

Neurofibromatosis 1 trial results

Related conditions